TCTR20151017004招募中未知
The seroprevalence of neutralizing antibody against Japanese encephalitis virus in health care workers
Sanofi Pasteur, Thailand0 个研究点目标入组 400 人开始时间: 2015年10月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 21 Years 至 60 Years（—）
- 性别
- All
入选标准
- •Medical personnel who underwent a medical examination in the year 2015 at Queen Sirikit National Institute of Child Health, and voluntarily join the study
排除标准
- •Who did not provided informed consent to a blood test
研究者
相似试验
Enrolling By Invitation
不适用
The seroprevalence of neutralizing antibody against Dengue virus in health care workersDengue fever riskDenguePRNTNeutralizing antibodySeroprevalenceSeroepidemiologySerological studyBangkokadultshealthcare workersThailandTCTR20160303002Sanofi Pasteur, Thailand402
招募中
不适用
Identification of neutralizing antibodies against severe or chronic infections of human beingDRKS00010169niversitätsklinikum Köln1,000
尚未招募
不适用
Detection of Neutralizing Antibody Against SARS-CoV-2 in RT-PCR Confirmed COVID-19 Patient with Diverse Disease SeverityCOVID-19TCTR20210329003King Chulalongkorn Memorial Hospital Excellence Center Program,36
尚未招募
4 期
Antibody persistence at 6 months or more in individuals primed with 2 doses of an inactivated vaccine who received a heterologous or homologous third dose – extension of study RHH_001 and safety and immunogenicity of a 4th dose with recombinant covid-19 vaccine (AstraZeneca/Fiocruz) or mRNA covid-19 vaccine (Comirnaty, Pfizer/ Wyeth)Covid-19C08.730RBR-4b5kzhdInstituto D'Or de Pesquisa e Ensino
进行中（未招募）
4 期
Evaluating the persistence of protection of a 3rd dose of COVID vaccine and the safety and induced protection of a 4th dose of COVID-19 vaccines in previously vaccinated adultsISRCTN12022293niversity of Oxford1,168